Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study.
Sekmek S, Karahan I, Ucar G, Ceylan F, Bayram D, Seven I, Bölek H, Ürün Y, Yücel KB, Yazici O, Kadioglu A, Karacin C, Canaslan K, Atag E, Demirer S, Erdem GU, Ergun Y, Atak M, Koksal B, Kiran MM, Turkay DO, Civelek B, Yalcin B, Uncu D.
Sekmek S, et al. Among authors: karahan i.
Clin Transl Oncol. 2024 Aug;26(8):1878-1885. doi: 10.1007/s12094-024-03410-x. Epub 2024 Mar 7.
Clin Transl Oncol. 2024.
PMID: 38451412